CXCR4 and myocardial infarction: These beneficial effects were attributed to the upregulation of the Akt signaling pathway, suggesting that CXCR4-enriched exosomes may be a viable therapeutic strategy for promoting cell survival and angiogenesis after myocardial infarction [162].